Denosumab biosimilar by Celltrion for Osteoporosis: Likelihood of Approval

Denosumab biosimilar is under clinical development by Celltrion and currently in Phase I for Osteoporosis.

Study identifies genetic cause of severe seizures in children

Shortly after Kelly Cervantes’ daughter Adelaide was born, she started having terrible seizures. Doctors were unable to give her a solution, or even a cause.

August 28, 2024

I’m an anesthesiologist. Kenneth Smith’s execution by nitrogen gas was far from ‘textbook’

On Thursday evening, the state of Alabama executed Kenneth Eugene Smith by nitrogen gas. Now, there are dueling narratives about what happened. Alabama claims it

January 29, 2024

RSV Vaccines Show High Effectiveness Against Hospitalization in Older Adults

During the first season of use, respiratory syncytial virus (RSV) vaccination among older adults was associated with a substantially reduced risk of hospitalization, a test-negative,

September 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.